Kuo and first author Eric Benner, who now heads his own lab at Duke, were not expecting to study astrocytes. They planned to trace newborn neurons from the mouse subventricular zone (SVZ) in response to injury. The researchers presumed stem cells would produce neurons to fill in the damaged area; others have reported neuron efflux from the SVZ following ischemia (Thored et al., 2006). Kuo developed a system to label neural stem cells in the SVZ and their progeny with the red fluorescent protein tdTomato (see ARF related news story on Kuo et al., 2006). Benner created a blood clot in the cortex close to the SVZ and subsequently examined the brains for cells lit up with tdTomato. He and Kuo were surprised when all they saw were astrocytes. These arose a few days after the injury and migrated to the damaged site.

Were these migratory astrocytes typical, or might there be something special about them? Scientists have come to suspect that astrocytes are a diverse group of cells with many subclasses (Hochstim et al., 2008). Duke collaborator Cagla Eroglu suggested looking for different thrombospondin proteins to distinguish the SVZ astrocytes. Eroglu studies thrombospondins, which are extracellular matrix proteins involved in cell-cell interactions. Astrocytes secrete thrombospondins to nudge neurons to form synapses (see ARF related news story on Christopherson et al., 2005; Eroglu et al., 2009; Eroglu, 2009). Some thrombospondins influence wound healing and angiogenesis (Adams and Lawler, 2011). Trying these proteins was a “shot in the dark,” Kuo admitted, but it hit a bullseye. The astrocytes that responded to injury expressed 100-fold more thrombospondin 4 than typical cortical astrocytes. “They are not garden-variety astrocytes,” Kuo said.

Thrombospondin 4 turned out to be more than a convenient marker; it was required for astrocytes to proliferate in response to the blood clot. In thrombospondin 4 knockout mice, the injury continually bled. “We think that these [newborn] astrocytes are there to make the bleeding stop before recovery can begin,” Kuo said. The paper supports previous work indicating that astrocytes protect the brain during trauma and ischemia, noted Michael Sofroniew of the University of California, Los Angeles, in an e-mail to Alzforum (Faulkner et al., 2004).

Newborn Healers
In control mice (left), thrombospondin 4-positive astrocytes (red) from the SVZ migrate to injury sites, sealing off blood vessels (green). In mice lacking thrombospondin 4, astrocytes are few and disorganized, and blood leaks into the brain tissue. Image courtesy of Nature

What are the implications for human injury and disease? The first task, Kuo noted, will be to determine whether people have a similar population of thrombospondin 4-expressing astrocytes. If so, therapeutics to activate them following a brain injury might be beneficial.

Might these cells protect against neurodegeneration? “To date, most of the work on astrocytes in the field of neurodegenerative diseases such as Alzheimer’s has focused on ways astrocytes contribute to degeneration,” Sofroniew noted. “Instead, if the authors are correct, then these newly generated astrocytes … would seem most likely to be neuroprotective.”

Kuo speculated that SVZ-derived astrocytes might fight neuroinflammation by extinguishing small bleeds associated with aging. Perhaps, he suggested, failure of this repair mechanism could contribute to neurological disease. The diversity of astrocytes implies that treatments might have to be targeted to specific subclasses, he said.

“I think this result is quite interesting and important,” commented Ben Barres of Stanford University in Palo Alto, California, in an e-mail to Alzforum (see full comment below). “They raise the question of what type of reactive astrocyte is induced in Alzheimer’s.” Perhaps, he speculated, the SVZ-derived astrocytes are somehow unavailable to fix damage in the case of AD.—Amber Dance.

Reference:
Benner EJ, Luciano D, Jo R, Abdi K, Paez-Gonzalez P, Sheng H, Warner DS, Liu C, Eroglu C, Kuo CT. Protective astrogenesis from the SVZ niche after injury is controlled by Notch modulator Thbs4. Nature. 2013 Apr 24. Abstract